Personal Cfo Solutions, LLC Arvinas, Inc. Transaction History

Personal Cfo Solutions, LLC

  • $704 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$14.19 - $42.33 $70,950 - $211,650
5,000 New
5,000 $205,000
Q3 2021

Nov 18, 2021
BUY
$73.2 - $107.87 $366,000 - $539,350
5,000 New
5,000 $411,000
Q1 2020

Apr 30, 2020
SELL
$33.0 - $54.5 $165,000 - $272,500
-5,000 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
$15.39 - $44.38 $76,950 - $221,900
5,000 New
5,000 $205,000

Others Institutions Holding ARVN

# of Institutions
229
Shares Held
68.4M
Call Options Held
226K
Put Options Held
285K
View Full List

About ARVINAS, INC.

ARVN Quotes by TradingView
  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.02B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Personal Cfo Solutions, LLC Portfolio

Follow Personal Cfo Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Personal Cfo Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Personal Cfo Solutions, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email